VivoSense is an agile end-to-end scientific solutions company measuring patient outcomes by developing novel digital endpoints from wearable sensor data. Our hypothesis-driven framework provides analytical and clinical validation leading to FDA approval. We develop novel digital biomarkers from wearable sensor data that constitute primary and secondary clinical endpoints in regulated international pharmaceutical trials. VivoSense is a proven, repeatable approach to digital outcome measures and endpoints